Re: 'Kakkos et al. Efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials'

Eur J Vasc Endovasc Surg. 2015 Mar;49(3):353. doi: 10.1016/j.ejvs.2014.11.019. Epub 2014 Dec 30.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticoagulants / therapeutic use*
  • Benzimidazoles / therapeutic use*
  • Humans
  • Morpholines / therapeutic use*
  • Pyrazoles / therapeutic use*
  • Pyridines / therapeutic use*
  • Pyridones / therapeutic use*
  • Secondary Prevention*
  • Thiazoles / therapeutic use*
  • Thiophenes / therapeutic use*
  • Venous Thromboembolism / drug therapy*
  • beta-Alanine / analogs & derivatives*

Substances

  • Anticoagulants
  • Benzimidazoles
  • Morpholines
  • Pyrazoles
  • Pyridines
  • Pyridones
  • Thiazoles
  • Thiophenes
  • beta-Alanine